Areej El-Jawahri, MD

Position / Title
Associate Director, Cancer Outcomes Research and Education Program
Institution
Massachusetts General Hospital
Other Disease Area(s) of Focus
chronic leukemias, lymphomas, and myelomas

Dr. El-Jawahri is an oncologist: (on-KAH-luh-jist) A doctor who specializes in the treatment and prevention of cancer. specializing in the care of patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation. Clinically, she takes care of patients with acute leukemia, myelodysplastic syndrome, chronic leukemias, lymphomas, and myelomas.  Her research interests include investigating patient-reported outcomes, enhancing patient-centered decision-making interventions, and designing supportive care: Care given to improve the quality of life, or comfort, of a person with a chronic illness. Supportive care treats the symptoms rather than the underlying cause of a disease. The goal is to help the patient feel better. Patients with low blood counts may be given blood transfusions as supportive… interventions to improve the care of patients with hematologic malignancies with a special emphasis on patients undergoing hematopoietic stem cell transplantation. Her research also explores models of health care delivery to improve patients' quality of life and clinical outcomes. She is an active member of the MGH Cancer Outcomes Research and Education Program (CORE).  She will also be leading efforts in building and developing the MGH Bone Marrow: The soft, spongy tissue inside most bones. Blood cells are formed in the bone marrow. Transplantation Survivorship Program.  She has led and conducted multiple clinical trials: Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study. Understanding Clinical Trials Clinical… focusing on enhancing the experience and clinical outcomes of patients with hematologic malignancies.

Physician Status